Breast Cancer Canada: Neoadjuvant Equity and Outcomes Research Matching Grants
Research Admin Offices:
- HRS
Funding Type:
GrantOpportunity Type:
- Grant
Value:
Up to $100,000.
Disciplines:
- Health Sciences
Sponsors:
- Breast Cancer Canada
Deadlines:
Internal Deadline:
August 2, 2024Sponsor Deadline:
September 30, 2024Additional Dates:
- LOI HRS Due Date: ASAP -
- LOI Sponsor Due Date - August 2, 2024
- Application Due Date (by invitation) - September 30, 2024
Description:
This opportunity supports the development of novel programs to improve accessible referrals for neoadjuvant therapy in early-stage breast cancer and report on clinical and patient reported outcomes.
Resources:
Contact:
If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.